|Videos|May 2, 2023
Interview with Jubilant’s President Chris Preti
Author(s)Jubilant
Key Learning Objectives:
- Progress on previously announced $285 million expansion plan will double capacity for sterile injectables fill/finish at Jubilant HollisterStier’s Spokane, Wash. Facility
- Strengthen’s Jubilant HollisterStier’s position in addressing contract manufacturing needs of major producers throughout North America
- Jubilant HollisterStier is a leading contract manufacturer of sterile injectables, ophthalmics, optics, sterile and non-sterile topicals and liquids
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
3
Shaping the Future of Microbial Development: From Gene to GMP
4
PharmTech Weekly Roundup - February 6, 2026
5